K2 THERAPEUTICS, INC.

New Filing
CIK: 0001610618·Biotechnology·DELAWARE·Filed: Jun 17, 2014
Total Offering

$42,743,763

Amount Sold

$30,332,199

Investors

8

First Sale

May 30, 2014

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2012
Non-Accredited Investors
No

Related Persons

NameRole
Jeffrey Stein
Related Person
Kevin Forrest
Related Person
Kevin Judice
Related Person
Dan Burgess
Related Person
Scott Rocklage
Related Person
Ted Schroeder
Related Person
Steve Elms
Related Person
Patrick Heron
Related Person
Nina Kjellson
Related Person

Company

Cidara Therapeutics, Inc.

6310 NANCY RIDGE DRIVE

SAN DIEGO, CA, 92121

781-314-1105

SEC Filing

0001610618-14-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free